Literature DB >> 2189665

Obliterative bronchiolitis.

J Theodore1, V A Starnes, N J Lewiston.   

Abstract

The mass of evidence suggests that OB is a manifestation of allograft rejection in the time period later than that usually associated with acute postoperative rejection. Respiratory infection may serve to amplify (and possibly trigger) this process. A maintenance immunosuppression regimen utilizing cyclosporine A, prednisone, and azathioprine appears to be much more effective than an earlier regimen utilizing only the first two drugs. Aggressive surveillance utilizing prospective measurement of pulmonary function and arterial blood gases and a willingness to look for histologic evidence of OB with the earliest symptomatology has lowered significantly the mortality and the morbidity of this disorder at Stanford and elsewhere. We believe that the current ability to treat and even reverse this serious complication brightens the prospect of heart-lung and lung transplantation for assuming a role in the medical practice of the future.

Entities:  

Mesh:

Year:  1990        PMID: 2189665

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  5 in total

1.  Lung transplantation.

Authors:  E C Lawrence; J Theodore; V A Starnes
Journal:  West J Med       Date:  1992-08

2.  T cell receptor biases and clonal proliferations among lung transplant recipients with obliterative bronchiolitis.

Authors:  S R Duncan; V Valentine; M Roglic; D J Elias; K W Pekny; J Theodore; D H Kono; A N Theofilopoulos
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

3.  IL-16 in the airways of lung allograft recipients with acute rejection or obliterative bronchiolitis.

Authors:  M Laan; A Lindén; G C Riise
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

Review 4.  Lung transplantation.

Authors:  L T Tanoue
Journal:  Lung       Date:  1992       Impact factor: 2.584

5.  Bronchiolitis obliterans after allogenic bone marrow transplantation: HRCT findings.

Authors:  Jung Im Jung; Won Sang Jung; Seong Tai Hahn; Chang Ki Min; Chun Choo Kim; Seog Hee Park
Journal:  Korean J Radiol       Date:  2004 Apr-Jun       Impact factor: 3.500

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.